Danny Edwards joins a seminar on governance and corruption at University of Toronto
29 September, 2017
On September 29, 2017, Danny Edwards, Research Programme Manager for the Access to Medicine Index, will join a one-day workshop on governance and corruption in the pharmaceutical sector that will be held at University of Toronto. This event will provide health care professionals and researchers with the opportunity to gain a better understanding of how corruption and lack of good governance can have an impact on pharmaceutical services and how to counter vulnerabilities within the sector.
Danny will lead a seminar on incentivising company performance in fighting corruption based on the work of the Access to Medicine Foundation. He will share the findings of the 2016 Access to Medicine Index, which analysed the access-to-medicine strategies of the world’s largest pharmaceutical companies alongside their compliance systems to pursue the highest ethical standards in all of the countries where they do business. He will also describe developments in the updated methodology for the Access to Medicine Index, in anticipation of the next iteration, due at the end of 2018.
Each Access to Medicine Index is the product of a two-year process known as the ‘Index cycle’, which begins with a review of the Index methodology that is now underway. Currently, the Index team is reviewing the Index methodology drawing on feedback from independent experts and stakeholders active in access to medicine. The aim is to align the methodology with changes in access-to-medicine priorities and expectations as to how pharmaceutical companies can make their products available, accessible and affordable to people living in developing countries. The methodology report will be published at the beginning of October 2017.